David Hart
Neurology · Albany, NYNPI 1245289990
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,335 of the $49,556 with a category attached, or 87.4%. Lilly USA, LLC accounts for 73.3% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $20,419, more than ten times the $982 reported in 2019. Among neurology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $576.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$36K
- Biogen$12K
- Eisai Inc.$970
- AbbVie$40
- E.r. Squibb & Sons, L.L.C.$38
- Amgen$30
- plus $12 from 1 others
Across 364 payments — averaging $4463.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$883K
- Biogen$298K
- Genentech, Inc.$297K
- Eli Lilly$146K
What the payments were for
- Consulting fees$1,1302%
- Speaking & faculty fees$43,33587%
- Travel & lodging$3,8108%
- Food & beverage$1,2523%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 52 | $36,334 |
| Biogen | 15 | $12,132 |
| Eisai Inc. | 13 | $970 |
| AbbVie | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Amgen | 1 | $30 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$49,556 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Donepezil Hcl | 17 | $631 |
| Memantine Hcl | 18 | $429 |
Paid to pharmacies, not to this prescriber.
Other neurology in Albany
- Charles ArgoffAlbany$1.2M
- Stanley PencAlbany$657K
- Angela ApplebeeAlbany$537K
- Krupa PandeyAlbany$433K
- Timothy LynchAlbany$265K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Stephen KriegerNew York$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.